Skip to content

Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome

Autonomic Dysfunction and Spinal Cord Stimulator in Complex Regional Pain Syndrome

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00780390
Acronym
CRPS
Enrollment
10
Registered
2008-10-27
Start date
2008-01-01
Completion date
2010-01-01
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndrome

Keywords

RSD, SCS, CRPS

Brief summary

To demonstrate that spinal cord stimulator has an effect on sympathetic function (the one that give us the fight and flight response). Therefore, if the spinal cord stimulator has an effect on sympathetic function, the responses from CRPS patients to different stimuli will differ significantly pre and post SCS implant. If CRPS patients exhibit autonomic, CRPS patients could be stratified according to their sympathetic function pre-implant. It is expected that patients with a moderate/mild form of autonomic dysfunction will have better outcomes with the SCS.

Detailed description

Currently the mechanisms of Complex Regional Pain Syndrome (CRPS) are poorly understood and stratification of either diagnosis or therapy is very weak. . There is a great need to develop and validate more objective methods to characterize and stratify CRPS that better diagnostic and therapeutic approaches are available. Spinal Cord Stimulation (SCS) has been used as the last resource to alleviate pain and re-establish function in CRPS patients. However, there is a disagreement over how it works. An underlying concept is that it works by modulating autonomic nervous system (ANS) activity. Therefore, ANS parameters could be useful to stratify patients. Our preliminary studies indicated that SCS has also an effect on blood pressure regulation and improves the CRPS patients' response to Valsalva maneuver -a test of autonomic function. The Autonomic Nervous System function in adult CRPS patients has not yet been studied. The only existing study of CRPS and autonomic function showed that 15% of the patients suffer from syncope and increased heart rate during upright position similar to same aged patients with postural tachycardia syndrome - a syndrome of autonomic dysfunction. It is unclear if autonomic dysfunction is present in CRPS patients because ANS activity is altered by chronic pain or whether or not ANS activity contributes to CRPS. Therefore, we proposed to study the autonomic function in CRPS patients by standardized autonomic function and to evaluate the effect of the SCS on autonomic function in CRPS patients before and after spinal cord stimulator implant. This is a 24 months study.

Interventions

OTHERAutonomic Function Assessment

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* CRPS patients meeting the inclusion criteria according to the International Association for the Study of pain task Force will be included in the study. * Age: 18 to 65. * Disease duration of at least 6 months. * History of unsuccessful long lasting therapies: physical therapy, transcutaneous electrical stimulation and medication.

Exclusion criteria

* Presence of current or past pulmonary, hepatic, renal disease, arthritis, hematopoietic, and neurological diseases not related to CRPS. * Anticoagulant therapy, cardiac pacemaker used. * Pregnancy test for females is positive.

Design outcomes

Primary

MeasureTime frameDescription
Change in muscle sympathetic nerve activityAt baseline and within 2 yearsElectrical neurography data from sympathetic nerves

Secondary

MeasureTime frameDescription
Heart rateAt baseline and within 2 yearsHeart rate (bpm)
Blood pressure responseAt baseline and within 2 yearsBlood pressure (mmHg)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPeter Konrad, M.D.

Vanderbilt University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026